This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
J. T. Bell et al. (2011). DNA methylation patterns associate with genetic and gene expression variation in HapMap cell lines. Genome Biology, 12, R10.
P. Chalise , E. Chicken and D. McGee (2011) Baseline age effect on parameter estimates in Cox models. Journal of Statistical Computation and Simulation, 82, 1767–1774.
Y. F. Chuang et al. (2010). Association between APOE epsilon4 allele and vascular dementia: the Cache County study. Dementia and Geriatric Cognitive Disorders, 29, 248–253.
R. M. Corbo and R. Scacchi (1999). Apolipoprotein E (APOE) allele distribution in the world. Is APOE*4 a ‘thrifty’ allele? Annals of Human Genetics, 63, 301–310.
J. F. Degner et al. (2012). DNase I sensitivity QTLs are a jamor determinant of human expression variation. Nature, 482, 390–394.
R. M. Evans et al. (2000). Serum cholesterol, APOE genotype, and the risk of Alzheimer's disease: a population-based study of African Americans. Neurology, 54, 240–242.
L. A. Farrer et al. (1997). Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA, 278, 1349–1356.
C. E. Finch and R. M. Sapolsky (1999). The evolution of Alzheimer disease, the reproductive schedule, and APOE isoforms. Neurobiology of Aging, 20, 407–428.
K. S. Hall , S. Gao , C. L. Emsley , A. O. Ogunniyi , O. Morgan and H. C. Hendrie (2000). Community screening interview for dementia (CSI ‘D’); performance in five disparate study sites. International Journal of Geriatric Psychiatry, 15, 521–531.
K. Hall et al. (2006) Cholesterol, APOE genotype, and Alzheimer disease: an epidemiologic study of Nigerian Yoruba. Neurology, 66, 223–227.
H. C. Hendrie et al. (1988). The CAMDEX: a standardized instrument for the diagnosis of mental disorder in the elderly: a replication with a US sample. Journal of the American Geriatrics Society, 36, 402–408.
H. C. Hendrie et al. (2001). Incidence of dementia and Alzheimer disease in 2 communities: Yoruba residing in Ibadan, Nigeria, and African Americans residing in Indianapolis, Indiana. JAMA, 285, 739–747.
L. H. Kuller et al. (1998). Relationship between ApoE, MRI findings, and cognitive function in the Cardiovascular Health Study. Stroke, 29, 388–398.
K. Leffondre , C. Touraine , C. Helmer and P. Joly (2013). Internal-censored time-to-event and competing risk with death: is the illness-death model more accurate than the Cox model? International Journal of Epidemiology, 42, 1177–1186.
G. M. Martin (1999). APOE alleles and lipophylic pathogens. Neurobiol Aging, 20, 441–443.
G. McKhann , D. Drachman , M. Folstein , R. Katzman , D. Price and E. M. Stadlan (1984). Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology, 34, 939–944.
J. R. Murrell et al. (2006). Association of apolipoprotein E genotype and Alzheimer disease in African Americans. Archives of Neurology, 63, 431–434.
T. Ohara et al. (2011). Apolipoprotein genotype for prediction of Alzheimer's disease in older Japanese: the Hisayama Study. Journal of the American Geriatrics Society, 59, 1074–1079.
C. Reitz et al. (2013). Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E 4,and the risk of late-onset Alzheimer disease in African Americans. JAMA, 309, 1483–1492.
K. Sawyer , N. Sachs-Ericsson , K. J. Preacher and D. G. Blazer (2009). Racial differences in the influence of the APOE epsilon 4 allele on cognitive decline in a sample of community-dwelling older adults. Gerontology, 55, 32–40.
R. Stewart , C. Russ , M. Richards , C. Brayne , S. Lovestone and A. Mann (2001). Apolipoprotein E genotype, vascular risk and early cognitive impairment in an African Caribbean population. Dementia and Geriatric Cognitive Disorders, 12, 251–256.
J. A. Tennessen et al. (2012). Evolution and functional impact of rare coding variation from deep sequencing of human exomes. Science, 337, 64–69.
S. A. Tishkoff et al. (2009). The genetic risk structure and history of Africans and African Americans. Science, 324, 1035–1044.
F. W. Unverzagt et al. (2011). Incidence and risk factors for cognitive impairment no dementia and mild cognitive impairment in African Americans. Alzheimer Disease and Associated Disorders, 25, 4–10.